Systematic review of 23 RCTs (2028 participants): in chronic musculoskeletal pain, melatonin did not significantly reduce pain vs placebo (MD −6.76/100, 95% CI −15.89 to 2.36) but beat active controls (MD −11.21/100); low-to-moderate certainty, mostly below MCID.
Meta-analysisn = 2,028
Wu et al. Efficacy and effectiveness of melatonin for the management of musculoskeletal pain: a systematic review and meta-analysis of placebo and active controlled trials